RYALTRIS 25 µg / 600 µg nasal spray 240 dos

7680696720036 CH-69672 R01AD59 12.02.3.

Active substances:

No images available

Details

Product number
6967201
CPT
-
Packaging group
240
Unit
Einzeldose(n)
Composition
mometasoni furoas 0.25 mg ut mometasoni furoas monohydricus, olopatadinum 6 mg ut olopatadini hydrochloridum, cellulosum microcristallinum et carmellosum natricum, dinatrii phosphas heptahydricus, carmellosum natricum, natrii chloridum, benzalkonii chloridum 0.2 mg, glycerolum, dinatrii edetas, polysorbatum 80, acidum hydrochloridum concentratum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 1 g corresp. mometasoni furoas 25 µg et olopatadinum 600 µg pro dosi.

Articles (1)

Ryaltris 25 μg / 600 μg, Nasenspray, Suspension
Nasenspray
240
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/09/2026
Patient information leaflet
Français
01/09/2026
Patient information leaflet
Italien
01/09/2026
Professional SmPC
Allemand
01/09/2026
Professional SmPC
Français
01/09/2026
Professional SmPC
Italien
01/09/2026

Detailed composition

Substance Quantity Type Category
mometasoni furoas
0.25 MG Substance Wirkstoff (Principe actif)
mometasoni furoas monohydricus
- Substance WIZUS
olopatadinum
6.0 MG Substance Wirkstoff (Principe actif)
olopatadini hydrochloridum
- Substance WIZUS
cellulosum microcristallinum et carmellosum natricum
- Substance HNIDK
dinatrii phosphas heptahydricus
- Substance HNIDK
carmellosum natricum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
benzalkonii chloridum
0.2 MG Substance HBESI
glycerolum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
acidum hydrochloridum concentratum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
mometasoni furoas
25.0 UG Substance Wirkstoff (Principe actif)
olopatadinum
600.0 UG Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 30.80
Specialties list
Yes
Generic
No
SL addition date: 01/09/2026

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
69672
Drug name
Ryaltris, Nasenspray, Suspension
Galenic form
NASSS
ATC Code
R01AD59
Authorization status
Z
Dispensation category
B
First authorization
23/06/2025
Authorization expiration date
22/06/2030
IT number
12.02.3.
Domain
Human medicine
Field of application
Allergische Rhinitis

Packaging details

Description (FR)
RYALTRIS 25 µg / 600 µg nasal spray 240 dos
Description (DE)
RYALTRIS 25 µg / 600 µg Nasenspray 240 Dos
Market launch
01/09/2026
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data